This site is intended for Healthcare Professionals only.

New Information Standard is out to reduce medical errors, improve patient safety


Share post:

A new Information Standard has been published to support improved medication and sharing of allergy information across healthcare services in England.

The move will standardise medication message content and help reduce medicines related errors and improve patient safety.

It will also allow efficient sharing of medicine information between NHS and social care organisations, including hospitals, GP practices, residential care homes, mental health trusts, and community pharmacies.

The Standard that came into effect in October “will save healthcare professionals valuable time accessing key medicines information, provide clinicians with access to a richer source of information, consistent across all care settings”, said Shahzad Ali, NHS Digital clinical lead for the Interoperable Medicines Programme.

The Standard was commissioned by NHSX and developed by NHSX and NHS Digital in consultation with INTEROPen, The Professional Record Standards Body, UK FHIR and The Interoperable Medicine Standards Working Group.

Dr Simon Eccles, deputy CEO of NHSX and national chief clinical information officer said the collaborative effort “will make a real difference to the care and support local clinicians can provide to their patients.”

NHS and social care organizations are required to be compliant with the Standard by March 31, 2023.


Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...